Germany: Aroundtown posts $360.21 million profit in Q1 2025
GDANSK:
Aroundtown
, one of
Germany
's largest-listed landlords, posted a first-quarter profit of 318.6 million euros ($360.21 million) on Wednesday, up three times year-on-year, as German commercial and residential property prices start to recover.
The profit, up from 102.3 million euros in the same period in 2024, follows Aroundtown's return to annual profitability in March after two years of losses as the country's real estate sector grappled with its worst crisis in decades.
Last month, German officials announced the loosening of a regulatory measure designed to soften the blow of a property crisis, a sign they are somewhat less worried about fallout from the country's troubled real estate sector.
The Luxembourg-based company said it had revalued 15% of its portfolio in the first quarter, reporting a 0.8% like-for-like value gain compared to December 2024.
First-quarter funds from operations (FFO I), a key metric for real estate companies, was almost unchanged from the same period a year earlier.
Aroundtown, which holds mostly office, residential and hotel properties, said it was benefiting from declining supply in its residential property locations, which include Berlin and London. Like-for-like rental growth increased by 4.5% compared with 1.6% for its office portfolio.
Aroundtown said it is seeing a growing "return to office" trend and expects office take-up growth of 8% in 2025, but it cautioned that geopolitical and economic uncertainties are making occupiers reluctant to make long-term commitments.
Though offices still make up the bulk of its portfolio, Frankfurt's largest listed office landlord is bolstering its residential business - partly by turning office spaces into serviced apartments.
Since the COVID-19 pandemic, the company has been converting some of its less sought-after office rentals. It said on Wednesday it expects most of its conversion projects to begin operations in 2026.
The realtor reaffirmed its 2025 outlook but opted not to recommend a dividend for 2024 for a third consecutive year, citing the need to "maintain a conservative financial position."
Shares in Aroundtown were up by 2.9% in morning trade.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
31 minutes ago
- Time of India
Saudi energy firm Alfanar lines up India green hydrogen play, awaits clear policy signals
Mumbai: Saudi Arabia-based energy giant, Alfanar Group , is preparing to enter India's green hydrogen segment once the country's policy and regulatory framework becomes clearer, Mohammed Irfan, chief executive officer, Alfanar Global Development - India, told ETEnergyWorld . The company has an annual revenue of Rs 620 crore. At present, it has wind power capacity of 506.5 MW operational in Gujarat and while 50 MW is under construction, he said. 'Our focus is on a mix of wind and solar hybrid projects, along with energy storage… We are preparing to enter the hydrogen segment once India's policy framework becomes clearer. Leveraging our international expertise, especially from Egypt and Chile, we aim to replicate successful models in India,' he said in an exclusive interview. He, however, added that while there was growing interest, India still lacked assured green hydrogen offtake agreements. 'Once India's hydrogen market matures in terms of regulatory and policy adaptation or guaranteed offtake emerges, we will definitely be a part of it. In contrast, India's renewable sector benefits from long-term PPAs with entities like NTPC, SECI, and others,' said Irfan. Apart from this, he added that their Saudi team is also working on developing green hydrogen projects in Egypt and green ammonia in Chile. The company is actively positioning itself as a key player in the global renewable energy transition and has developed a portfolio of about 1.7 GW of renewable energy projects across Spain, India, and Egypt. 'In Spain, we operate both wind and solar projects. In Egypt, we have a solar project, and in India, we have about 600 MW of wind projects operational,' said Irfan. The company is also developing a sustainable aviation fuel project in the United Kingdom. On the challenge of grid evacuation, Irfan said that power evacuation and grid connectivity at CTU/PGCIL substations are already constrained, as multiple independent power producers and land brokers have secured access through land acquisitions and bank guarantees for substations scheduled for commissioning up to 2030. As a result, the earliest available connectivity that can currently be applied for at the CTU level is for the year 2031.
Mint
an hour ago
- Mint
KKR, TPG eye Relisys Medical Devices in early-stage buyout talks
MUMBAI : Relisys Medical Devices is in early-stage discussions with global private equity firms KKR and TPG for a potential ₹1,200–1,300 crore investment, with the transaction likely to offer a full or partial exit to existing investor Siguler Guff, two people familiar with the matter told Mint. 'While TPG is evaluating the company to strengthen its portfolio, KKR is in discussions with the medical devices maker to build out its med-tech platform under which it acquired Healthium Medtech last year from Apax Funds," one of the people cited above said. TPG, too, may look at developing a med-tech platform of its own, the person added. A majority of the proceeds from the transaction, if it materialises, will likely be secondary in nature, enabling Siguler Guff to partially or fully exit. A smaller primary infusion may also be included to fund Relisys's expansion plans, said the second person. Both private equity firms are expected to seek a controlling stake in the Hyderabad-based medical devices maker. In secondary deals, existing shareholders sell their stakes to other investors and the company doesn't receive any new capital. Such shares are usually traded at a discount to primary equity. While KKR declined to comment, TPG, Siguler Guff, Healthium, and Relisys did not respond to Mint's mails sent on Sunday. Also read: Zydus bets big on vaccines and medtech In February, VCCircle had reported that o3 Capital, a mid-market investment bank, was advising Relisys in its search for potential buyers. The report also noted that existing investor Siguler Guff was exploring a full or partial exit, alongside the company's founders, in a transaction then estimated to be valued at $50–70 million ( ₹435–610 crore). Company background Founded in 1997 by technocrats and clinicians, Relisys Medical Devices manufactures cardiovascular products like drug-eluting stents, balloon catheters, diagnostic catheters, and transcatheter heart valves. It also acquired Multimedics in 2018 to expand its stent-making capabilities globally. In FY24, the company reported revenue of ₹169.4 crore, up slightly from ₹162.7 crore a year earlier. Net profit rose marginally to ₹36.3 crore, according to data from Tracxn. The bustling deal activity in the sector also underscores the growing investor appetite for med-tech companies in India. Some notable transactions include Meril Life Sciences $210 million funding from Warburg Pincus which also invested about $300 million in Appasamy Associates. SMT raised $150 million from Samara Capital while Translumina raised around $90 million from Everstone Capital. Also read: Health ministry to set up a panel to review medical device-related adverse events Sector outlook India's $12 billion med-tech market is projected to hit $50 billion by 2030, according to EY. Despite $3.8 billion in exports last fiscal, the country is still heavily import-dependent, with imports at $8.2 billion, making up 80–85% of domestic consumption. Growth is expected to be driven by rising income levels, wider insurance coverage, medical tourism, and rapid healthcare infrastructure expansion in Tier 2 and 3 cities. EY noted that global MNCs are increasingly choosing India for R&D, manufacturing, and global capability centers (GCCs)—further strengthening the ecosystem. Also read: India eyes global pharma dominance with a ₹5,000 crore revitalisation plan
Mint
an hour ago
- Mint
Rupee supported at open by dollar dip on US tariffs, fiscal concerns
MUMBAI, June 2 (Reuters) - The Indian rupee is expected to be supported at the open on Monday following a decline in the U.S. dollar due to tariff-related developments and fiscal concerns. The 1-month non-deliverable forward indicated an open in the 85.52-85.54 range, versus 85.5775 in the previous session. The dollar index slipped 0.2% while Asian currencies were mixed on the day. "Not much on the Asian front to guide the rupee today, with two-way flows likely to dominate in the 85.50–85.70 band," a currency trader at a Mumbai-based bank said. According to the trader, interbank players are looking to sell dollar/rupee on up ticks, with stops placed around the 86 mark. In recent sessions, the rupee has found support in the 85.60–85.70 zone, with bankers noting broad-based interest in selling dollars at those levels. The dollar kicked off the week on the defensive against its major peers, weighed down by ongoing uncertainty over U.S. tariffs. President Donald Trump announced late Friday his intention to double duties on imported steel and aluminium to 50%, effective Wednesday. This follows a U.S. trade court that initially blocked much of Trump's tariff plan, ruling that he had overstepped his authority. However, an appeals court later reinstated the bulk of those duties, reigniting market caution. The dollar has further been weighed down by fiscal worries in recent weeks. The U.S. Senate will consider Trump's sweeping tax cut and spending bill, which will add an estimated $3.8 trillion to the $36.2 trillion in debt over the next decade. "US growth and interest rates should continue to converge lower than in many other major economies", which should keep the dollar under pressure, ING Bank said. "And there's still a sizeable risk that fiscal credibility issues take their toll on US assets this summer." ** One-month non-deliverable rupee forward at 85.64; onshore one-month forward premium at 13.25 paisa ** Dollar index down at 99.2 ** Brent crude futures up 2.7% at $64.5 per barrel ** Ten-year U.S. note yield at 4.41% ** As per NSDL data, foreign investors sold a net $205.6mln worth of Indian shares on May 29 ** NSDL data shows foreign investors bought a net $3,412.8mln worth of Indian bonds on May 29 (Reporting by Nimesh Vora; Editing by Eileen Soreng)
